These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 22001879)

  • 1. Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.
    Denzler KL; Babas T; Rippeon A; Huynh T; Fukushima N; Rhodes L; Silvera PM; Jacobs BL
    Vaccine; 2011 Dec; 29(52):9684-90. PubMed ID: 22001879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus.
    Denzler KL; Schriewer J; Parker S; Werner C; Hartzler H; Hembrador E; Huynh T; Holechek S; Buller RM; Jacobs BL
    Vaccine; 2011 Dec; 29(52):9691-6. PubMed ID: 21983358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.
    Denzler KL; Rice AD; MacNeill AL; Fukushima N; Lindsey SF; Wallace G; Burrage AM; Smith AJ; Manning BR; Swetnam DM; Gray SA; Moyer RW; Jacobs BL
    Vaccine; 2011 Oct; 29(44):7659-69. PubMed ID: 21840358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus.
    Stittelaar KJ; van Amerongen G; Kondova I; Kuiken T; van Lavieren RF; Pistoor FH; Niesters HG; van Doornum G; van der Zeijst BA; Mateo L; Chaplin PJ; Osterhaus AD
    J Virol; 2005 Jun; 79(12):7845-51. PubMed ID: 15919938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
    Earl PL; Americo JL; Wyatt LS; Eller LA; Whitbeck JC; Cohen GH; Eisenberg RJ; Hartmann CJ; Jackson DL; Kulesh DA; Martinez MJ; Miller DM; Mucker EM; Shamblin JD; Zwiers SH; Huggins JW; Jahrling PB; Moss B
    Nature; 2004 Mar; 428(6979):182-5. PubMed ID: 15014500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
    Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y; Bray M; Whitehouse CA; Miller D; Mucker E; Manischewitz J; King LR; Robert-Guroff M; Hryniewicz A; Venzon D; Meseda C; Weir J; Nalca A; Livingston V; Wells J; Lewis MG; Huggins J; Zwiers SH; Golding H; Franchini G
    J Infect Dis; 2005 Feb; 191(3):372-81. PubMed ID: 15633096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
    Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M
    Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
    J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
    Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
    Nigam P; Earl PL; Americo JL; Sharma S; Wyatt LS; Edghill-Spano Y; Chennareddi LS; Silvera P; Moss B; Robinson HL; Amara RR
    Virology; 2007 Sep; 366(1):73-83. PubMed ID: 17507071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD; Cotsmire S; Trainor K; Harrington H; Hauns K; Kibler KV; Huynh TP; Jacobs BL
    J Virol; 2015 Oct; 89(20):10489-99. PubMed ID: 26246580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection.
    Stittelaar KJ; Neyts J; Naesens L; van Amerongen G; van Lavieren RF; Holý A; De Clercq E; Niesters HG; Fries E; Maas C; Mulder PG; van der Zeijst BA; Osterhaus AD
    Nature; 2006 Feb; 439(7077):745-8. PubMed ID: 16341204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.
    Edghill-Smith Y; Golding H; Manischewitz J; King LR; Scott D; Bray M; Nalca A; Hooper JW; Whitehouse CA; Schmitz JE; Reimann KA; Franchini G
    Nat Med; 2005 Jul; 11(7):740-7. PubMed ID: 15951823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
    Saijo M; Ami Y; Suzaki Y; Nagata N; Iwata N; Hasegawa H; Ogata M; Fukushi S; Mizutani T; Sata T; Kurata T; Kurane I; Morikawa S
    J Virol; 2006 Jun; 80(11):5179-88. PubMed ID: 16698998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
    Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge.
    Marriott KA; Parkinson CV; Morefield SI; Davenport R; Nichols R; Monath TP
    Vaccine; 2008 Jan; 26(4):581-8. PubMed ID: 18077063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection.
    Estep RD; Messaoudi I; O'Connor MA; Li H; Sprague J; Barron A; Engelmann F; Yen B; Powers MF; Jones JM; Robinson BA; Orzechowska BU; Manoharan M; Legasse A; Planer S; Wilk J; Axthelm MK; Wong SW
    J Virol; 2011 Sep; 85(18):9527-42. PubMed ID: 21752919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.